INVESTIGATING THE EFFECTS OF DRUG-DRUG INTERACTIONS ON THERAPEUTIC OUTCOMES AND PATIENT SAFETY
Main Article Content
Keywords
potential drug–drug interactions, pharmacokinetic, severity, revalence, patient safety.
Abstract
Multiple drug therapies are commonly used to achieve a desired therapeutic goal, especially in hospitalized patients. Drug interactions, however, could happen and jeopardize the patients' security.The purpose of this research is to examine how drug-drug interactions (DDIs) affect patient safety and therapeutic results, particularly in hospital settings. When two or more medications are taken at the same time, complicated phenomena known as drug interactions can happen that change the pharmacokinetic or pharmacodynamic consequences. Comprehending the effects of developmental disabilities is essential to maximizing drug schedules and guaranteeing patient welfare. Using a variety of data sources and analytical techniques, we take a thorough approach in this work to evaluate the impact of drug-drug interactions on therapeutic outcomes and patient safety.
Downloads
References
1. Makkaoui N, Halaoui A, Atoui Z, et al. Knowledge, attitudes, and practices regarding drug interactions among community pharmacists. J Public Heal. 2021;29(6):1357–1363. doi: 10.1007/s10389-020-01252-9 [CrossRef] [Google Scholar] 2. Tsui V, Thomas D, Tian S, et al. Adverse Drug Events, Medication Errors, and Drug Interactions. In: Clinical Pharmacy Education, Practice and Research. Elsevier; 2019:227–245. [Google Scholar] 3. Gebretsadik Z, Gebrehans M, Getnet D, Gebrie D, Alema T, Belay YB. Assessment of drug-drug interaction in ayder comprehensive specialized Hospital, Mekelle, Northern Ethiopia: a Retrospective Study. Biomed Res Int. 2017;2017:9792363. doi: 10.1155/2017/9792363 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 4. Snyder BD, Polasek TM, Doogue MP. Drug interactions: principles and practice. Aust Prescr. 2012;35(3):85–88. doi: 10.18773/austprescr.2012.037 [CrossRef] [Google Scholar] 5. Zheng WY, Richardson LC, Li L, Day RO, Westbrook JI, Baysari MT. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15–27. doi: 10.1007/s00228-017-2357-5 [PubMed] [CrossRef] [Google Scholar] 6. Shetty V, Chowta MN, Chowta KN, Shenoy A, Kamath A, Kamath P. Evaluation of potential drug-drug interactions with medications prescribed to geriatric patients in a tertiary care hospital. J Aging Res. 2018;2018:5728957. doi: 10.1155/2018/5728957 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 7. Georgiev KD, Hvarchanova N, Stoychev E, Kanazirev B. Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics. Sci Prog. 2022;105(1):003685042110701. doi: 10.1177/00368504211070183 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 8. Korucu FC, Senyigit E, Köstek O, et al. A retrospective study on potential drug interactions: a single center experience. J Oncol Sci. 2018;4(2):80–84. doi: 10.1016/j.jons.2018.06.001 [CrossRef] [Google Scholar] 9. Murtaza G, Yasir M, Khan G, Azhar S, Ali S, Khan TM. Assessment of potential drug – drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2016;24(2):220–225. doi: 10.1016/j.jsps.2015.03.009 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 10. Nusair MB, Al-azzam SI, Arabyat RM, Amawi HA, Alzoubi KH, Rabah AA. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan. Saudi Pharm J. 2020;28(2):155–160. doi: 10.1016/j.jsps.2019.11.009 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 11. Bhagavathula AS, Berhanie A, Tigistu H, et al. Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia. Asian Pac J Trop Biomed. 2014;4(Suppl 1):S204–8. doi: 10.12980/APJTB.4.2014C1172 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 12. Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407. doi: 10.2165/00002018-200730050-00003 [PubMed] [CrossRef] [Google Scholar] 13. Vonbach P, Dubied A, Krähenbühl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med. 2008;19(6):413–420. doi: 10.1016/j.ejim.2007.12.002 [PubMed] [CrossRef] [Google Scholar] 14. Ismail M, Iqbal Z, Khattak MB, et al. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan. Int J Clin Pharm. 2013;35(3):455–462. doi: 10.1007/s11096-013-9764-1 [PubMed] [CrossRef] [Google Scholar] 15. Osman MA, Abdalla MA, Mohamed AA, Yousef BA. Assessment of drug–drug interactions between chemotherapeutic and chronically used medications at Khartoum oncology hospital. Matrix Sci Medica. 2020;4(3):79–84. doi: 10.4103/MTSM.MTSM_17_20 [CrossRef] [Google Scholar] 16. Hamadouk RM, Albashair ED, Mohammed FM, Yousef BA. The practice of the community pharmacists in managing potential drug-drug interactions: a simulated patient visits. Integr Pharm Res Pract. 2022;11:71–84. doi: 10.2147/IPRP.S355675 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 17. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):1623–1627. doi: 10.1371/journal.pmed.0040296 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 18. Lexicomp® Drug Interact. Wolters Kluwer. Available from: https://online.lexi.com/loc/action/home. Accessed October 14, 2022. 19. Van LRWF, Swart EL, Boven E, Boom FA, Schuitenmaker MG, Hugtenburg JG. Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method. Ann Oncol. 2011;22(10):2334–2341. doi: 10.1093/annonc/mdq761 [PubMed] [CrossRef] [Google Scholar] 20. Abunahlah N, Elawaisi A, Velibeyoglu FM, Sancar M. Drug related problems identified by clinical pharmacist at the internal medicine Ward in Turkey. Int J Clin Pharm. 2018;40(2):360–367. doi: 10.1007/s11096-017-0585-5 [PubMed] [CrossRef] [Google Scholar] 21. World Health Organization. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions: Why Health Professionals Need to Take Action. Geneva: World Health Organization; 2002. [Google Scholar] 22. Teka F, Teklay G, Ayalew E, Teshome T. Potential drug-drug interactions among elderly patients admitted to medical ward of ayder referral hospital, Northern Ethiopia: a cross sectional study. BMC Res Notes. 2016;9(1):431. doi: 10.1186/s13104-016-2238-5 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 23. Mousavi S, Ghanbari G. Potential drug-drug interactions among hospitalized patients in a developing country. Casp J Intern Med. 2017;8(4):282–288. [PMC free article] [PubMed] [Google Scholar] 24. Kulkarni V, Bora SS, Sirisha S, Saji M, Sundaran S. A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital. Ther Adv Drug Saf. 2013;4(4):141–146. doi: 10.1177/2042098613490009 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 25. Doubova SV, Reyes-Morales H, Torres-Arreola LDP, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7(147). doi: 10.1186/1472-6963-7-147 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 26. Reimche L, Forster AJ, Van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol. 2011;51(7):1043–1050. doi: 10.1177/0091270010378858 [PubMed] [CrossRef] [Google Scholar] 27. Sepehri G, Khazaelli P, Dahooie FA, Sepehri E, Dehghani MR. Prevalence of potential drug interactions in an Iranian general hospital. Indian J Pharm Sci. 2012;74(1):75–79. doi: 10.4103/0250-474X.102548 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 28. Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwong V. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther. 2005;30(1):13–20. doi: 10.1111/j.1365-2710.2004.00598.x [PubMed] [CrossRef] [Google Scholar] 29. Moura C, Acurcio F, Belo N. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12(3):266–272. doi: 10.18433/J35C7Z [PubMed] [CrossRef] [Google Scholar] 30. Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99(8):592–600. doi: 10.1093/jnci/djk130 [PubMed] [CrossRef] [Google Scholar] 31. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58(11):773–778. doi: 10.1007/s00228-002-0557-z [PubMed] [CrossRef] [Google Scholar] 32. Andersson ML, Böttiger Y, Kockum H, Eiermann B. High prevalence of drug–drug interactions in primary health care is caused by prescriptions from other healthcare units. Basic Clin Pharmacol Toxicol. 2018;122(5):512–516. doi: 10.1111/bcpt.12939 [PubMed] [CrossRef] [Google Scholar] 33. Jazbar J, Locatelli I, Horvat N, Kos M. Clinically relevant potential drug–drug interactions among outpatients: a nationwide database study. Res Soc Adm Pharm. 2018;14(6):572–580. doi: 10.1016/j.sapharm.2017.07.004 [PubMed] [CrossRef] [Google Scholar] 34. Dirin MM, Mousavi S, Afshari AR, Tabrizian K, Ashrafi MH. Potential drug ‑ drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran. J Res Pharm Pract. 2014;3(3). doi: 10.4103/2279-042X.141118 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 35. Hasnain H, Ali H, Zafar F, et al. Drug-drug interaction; facts and comparisons with national and international bench marks. A threat more than a challenge for patient safety in clinical and economic scenario. Prof Med J. 2017;24(03):357–365. [Google Scholar] 36. Riaz MK. Potential drug-drug interactions and strategies for their detection and prevention. Farmacia. 2019;67(4):572–579. doi: 10.31925/farmacia.2019.4.3 [CrossRef] [Google Scholar] 37. Bojuwoye AO, Suleman F, Perumal-Pillay VA. Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa. J Pharm Policy Pract. 2022;15(1):1–12. doi: 10.1186/s40545-021-00401-z [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Issue
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.